Characterization of the interaction of Raf-1 with ras p21 or 14-3-3 protein in intact cells  by Koyama, Shinya et al.
FEBS 15758 FEBS Letters 368 (1995) 321-325 
Characterization of the interaction of Raf- 1 with ras  p21 or 14-3-3 protein 
in intact cells 
Shinya Koyama , Lewis T. Williams b, Akira Kikuchi a'* 
aDepartment of Biochemistry, Hiroshima University School of Medicine, Hiroshima 734, Japan 
bDaiichi Research Center, Cardiovascular Research Institute, University of California, San Francisco, CA 94143-0130, USA 
Received 15 May 1995; revised version received 6 June 1995 
Abstract Several deletion mutants of Raf-1 were expressed with 
v- ras  p21 or 14-3-3 protein in COS-7 cells and Sf9 cells and the 
interaction of Raf-1 with ras  p21 or with 14-3-3 protein in intact 
cells was examined. Raf(1-135) (residues 1-135) and Raf(1-322) 
interacted with v- ras  p21, but other deletion mutants such as 
Raf(136-322) or Raf(321-648) did not. Raf(1-322) interacted 
with 14-3-3 protein much more efficiently than Raf(321-648) did. 
While Raf(1-135) did not interact with 14-3-3 protein, Raf(136- 
322) did. These results clearly indicate that Raf-I simultaneously 
interacts with both ras  p21 and 14-3-3 protein through the distinct 
binding domains in intact cells. 
Key words." 14-3-3 Protein; ras p21; Raf-1; COS cell; 
Spodoptera frugiperda cell (Sf9 cell) 
I. Introduction 
Protein kinase Raf-1 is believed to be a key component of the 
signal transduction pathway leading to MAP kinase activation 
by extracellular signals [1,2]. Among the intracellular signals 
which activate Raf-1, the signal through ras p21 has been well 
studied [1,2]. Extracellular signals induce the conversion of the 
GDP-bound inactive form of ras p21 to the GTP-bound active 
form [3]. The GTP-bound form of ras p21 interacts with Raf-I 
[4-10]. The 81-amino acid fragment (residues 51 131) of Raf-1 
is a minimal ras p21-binding domain [8,11-14]. However, it has 
been reported that the interaction of Raf-1 with ras p21 is not 
sufficient for Raf-1 activation, suggesting that other factors are 
required for ras p21-dependent Raf-1 activation [1,10]. 
Several groups including us have found that the 14-3-3 family 
of proteins (14-3-3 protein) interacts with Raf-1 and stimulates 
this protein kinase activity [15-17]. 14-3-3 protein has been 
originally identified as a series of very abundant acidic proteins 
with a Mr of 30,000 in brain tissue [18]. At least seven mammal- 
ian isoforms have been identified, and 14-3-3 protein exhibits 
multiple functions uch as an activator of tyrosine and trypto- 
phan hydroxylase or a potent inhibitor of protein kinase C 
[18-22]. Our results have shown that 14-3-3 protein associates 
with and activates Raf-1 in Xenopus oocytes and that 14-3-3 
protein induces oocyte maturation through Raf-1 [17]. The 
N-terminal domain of Raf-1 binds to 14-3-3 protein more effi- 
ciently than the C-terminal domain in yeast wo-hybrid system 
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[15-17]. However, 14-3-3 protein-binding domain of Raf- 1 has 
not yet been characterized in intact cells. 
To understand how ras p21 and 14-3-3 protein activate Raf- 
1, we have analyzed the binding domains of Raf-1 for ras p21 
and 14-3-3 protein using intact cells. Here we demonstrate hat 
the binding domain of Raf-1 for ras p21 is distinct from the 
14-3-3 protein-binding domain in intact cells. 
2. Materials and methods 
2.1. Materials" 
Mammalian expression vectors, pCGN and pBJ-1, and the mouse 
anti-influenza virus HA1 monoclonal ntibody 12CA5 [23] were pro- 
vided by Dr. Q. Hu (University of California, San Francisco, CA, 
USA). pCGN was designed to express an influenza virus HA epitope 
fused protein which was recognized by the antibody 12CA5. The bacu- 
lovirus carrying the Myc-14-3-3( cDNA, pBJ/Myc-14-3-3~', and the 
mouse anti-Myc monoclonal ntibody 9El0 were provided by Dr. A. 
Klippel (Chiron Corp., CA, USA). 14-3-3( protein was tagged at the 
N-terminus with a Myc epitope which was recognized by the antibody 
9El0. COS-7 cells were obtained from the American Type Culture 
Collection. 14-3-3~" cDNA was isolated as a Raf-interacting molecule 
by yeast wo-hybrid method [17]. v-ras p21, Raf-1, GST fused to the 
N-terminal domain of Raf-I (amino acids 1 322) (GST-N-Raf), and 
GST fused to the C-terminal domain of Raf-I (amino acids 321-648) 
(GST-C-Raf) were expressed in Sf9 cells as described [10,24]. Other 
materials were obtained as described [10,25]. 
2.2 Plasmid constructions 
The fragments of the human Raf-1 cDNA sequence corresponding 
to amino acid residues 1 60, 1-135, 1-196, 61-322, 81-322, 106-322, 
13~322, 1-322, and 321-648 were synthesized by a PCR. These PCR 
fragments were designed to have XbaI and PstI sites at the 5'-end and 
the 3'-end, respectively. These PCR fragments were digested with Xbal 
and PstI and the PstI site was blunted with Klenow. Then the PCR 
fragments were inserted in the XbaI and SmaI cut pCGN. To construct 
pBJ-1 encoding v-ras p21, the 0.6 kb fragments containing v-ras p21 
with the XbaI and BamHI sites was synthesized by PCR. This fragment 
was digested with XbaI and BamHI and inserted into the XbaI and 
BamHI cut pBJ-l. 
2.3. Interaction assay of Raf-1 with rasp21 and l4-3-3 protein in COS-7 
cells and Sf) cells 
COS-7 cells were cultured as described [26]. COS-7 cells were trans- 
fected with pCGN- and pBJ-derived constructs described above by the 
DEAE-dextran method [27]. Sixty hours after transfection, the cells 
were lysed [26]. The proteins of the lysates (160/lg of protein) were 
immunoprecipitated with the anti-ras p21 (Y 13-238) or anti-Myc anti- 
body [25,26]. The precipitates were probed with the anti-HA antibody. 
Monolayers of St9 cells were infected with high-titer recombinant bacu- 
loviruses [24]. Seventy-two hours after infection, the cells were lysed 
[10]. The proteins of the lysates (240/lg of protein) were immunoprecip- 
itated with the anti-Raf-1 antibody or precipitated with glutathione 
Sepharose 4B [10]. The precipitates were probed with the anti-Raf-l, 
anti-ras p21, anti-HA, or anti-Myc antibody. 
2.4. Other determinations 
Protein concentrations were determined with bovine serum albumin 
as a standard [28]. 
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Fig. 1. Interaction of Raf-1 deletion mutants with ras p21 in COS cells. 
(A) Expression of Raf-1 deletion mutants. Aliquots (10/zl each) of the 
lysates expressing v-ras p21 and Raf(1-60) (lane I), Raf(1-135) (lane 
2), Raf(1-196) (lane 3), Raf(61-322) (lane 4), Raf(81-322) (lane 5), 
Raf(106-322) (lane 6), Raf(136-322) (lane 7), Raf(1-322) (lane 8), or 
Raf(321~48) (lane 9) were probed with the anti-HA antibody. 
(B) Interaction of Raf-1 deletion mutants with ras p21. The lysates 
expressing v-ras p21 and Raf-I mutants described above were im- 
munoprecipitated with the anti-ras p21 antibody (Y13-238). Arrow 
heads indicate the precipitated Raf-1 mutants. The results hown are 
representative of three independent experiments. 
3. Results 
To characterize the ras  p21-binding domain of Raf- 1 in intact 
cells, we made a series of the N- and C-terminal deletion mu- 
tants of Raf-1 and expressed them with v- ras  p21 in COS cells. 
These Raf-1 deletion mutants were expressed as HA-tagged 
proteins. The expression levels of transfected Raf-1 deletion 
mutants were similar as assessed by immunoblotting using the 
anti-HA antibody (Fig. 1A). The expression levels of trans- 
fected v- ras  p21 were also similar in these cells (data not 
shown). When the lysates expressing the Raf- 1 deletion mutants 
and v- ras  p21 were immunoprecipitated with the ant i - ras  p21 
antibody, Raf(1-135), Raf(1-196), and Raf(1-322) were de- 
tected in the ras  p21 immune complex (Fig. 1B, lanes 2, 3 and 
8). However, none of Raf(1-60), Raf(61-322), Raf(81-322), 
Raf(106-322), Raf(136-322), or Raf(321 648) was immunopre- 
cipitated with ras  p21 (Fig. 1B, lanes 1, 4-7, and 9). 
Next we characterized the interaction of Raf-1 and 14-3-3 
protein in Sf9 cells. 14-3-3 protein was expressed as a Myc- 
tagged protein. The expression level of transfected 14-3-3 pro- 
tein alone was similar to that in the cells expressing Raf-1 and 
14-3-3 protein as assessed by immunoblotting using the anti- 
Myc antibody (Fig. 2A). When the lysates expressing Raf- 1 and 
14-3-3 protein were immunoprecipitated with the anti-Raf-1 
antibody, both Raf-1 and 14-3-3 protein were detected in the 
Raf-1 immune complex (Fig. 2B, lane 3). When the lysates 
expressing Raf-1 alone or 14-3-3 protein alone were im- 
munoprecipitated with the anti-Raf-1 antibody, 14-3-3 protein 
was not detected (Fig. 2B, lanes 1 and 2). Neither Raf-1 nor 
14-3-3 protein was immunoprecipitated with non-immune 
serum from the lysates expressing both proteins (Fig. 2B, lane 
4). To characterize the interaction of Raf-1 and 14-3-3 protein 
further, we expressed 14-3-3 protein with GST-N-Raf or GST- 
C-Raf in Sf9 cells. GST-N-Raf and GST-C-Raf were expressed 
as HA-tagged proteins. The expression levels of transfected 
GST-N-Raf and GST-C-Raf were similar as assessed by im- 
munoblotting using the anti-HA antibody (Fig. 2C, lanes 1 and 
2). The expression levels of transfected 14-3-3 protein were also 
similar in these cells (Fig. 2C, lanes 1 and 2). When the lysates 
expressing GST-N-Raf and 14-3-3 protein were precipitated 
with glutathione Sepharose 4B, GST-N-Raf was precipitated 
with 14-3-3 protein (Fig. 2C, lane 3). However, GST-C-Raf 
bound to 14-3-3 protein very weakly (Fig. 2C, lane 4). These 
results are consistent with the recent observations of the inter- 
action of Raf-1 and 14-3-3 in vitro [29]. Furthermore, we exam- 
ined the interaction of Raf-1, v- ras  p21, and 14-3-3 proteins in 
St9 cells. Both v- ras  p21 and 14-3-3 protein were immunopre- 
cipitated with Raf-1 (Fig. 2D, lane 3). The binding of ras  p21 
to Raf-1 was not found to affect hat of 14-3-3 protein to Raf-I 
(Fig. 2D, lanes 1-3). 
These observations prompted us to examine whether the ras  
p21-binding and 14-3-3 protein-binding domains of Raf- 1 were 
separate. We expressed 14-3-3 protein and Raf-1 deletion mu- 
tants in COS cells. 14-3-3 protein was expressed as a Myc- 
tagged protein. The expression levels of transfected 14-3-3 pro- 
tein were similar in these cells (data not shown). Raf(1-322) and 
Raf(136-322) were immunoprecipitated with 14-3-3 protein, 
i )  
Fig. 2. Interaction of Raf-1 with 14-3-3 protein in Sf9 cells. (A) Expression of Raf-1 and 14-3-3 protein. Aliquots (10 gl) of Sf9 cells expressing no 
protein (lane 1), Raf-1 alone (lane 2), 14-3-3 protein alone (lane 3), or both proteins (lane 4) were probed with the anti-Raf-1 and anti-Myc antibodies. 
An arrow and an arrowhead indicate the positions of Raf-1 and 14-3-3 protein, respectively. (B) Interaction of Raf-1 with 14-3-3 protein. The lysates 
expressing Raf-I alone (lane 1), 14-3-3 protein alone (lane 2), or both proteins (lanes 3 and 4) were immunoprecipitated with the anti-Raf-1 antibody 
(lanes 1-3) or non-immune serum (lane 4). (C) Interaction of 14-3-3 protein with N-terminal domain of Raf-1. The lysates expressing GST-N-Raf 
and 14-3-3 protein (lanes 1 and 3) or GST-C-Raf and 14-3-3 protein (lanes 2 and 4) were lysed and aliquots (10/zl each) of the lysates were probed 
with the anti-HA and anti-Myc antibodies (lanes I and 2). The proteins of the lysates were precipitated with glutathione Sepharose 4B (lanes 3 and 
4). An arrow indicates the positions of GST-N-Raf and GST-C-Raf. An arrowhead indicates the position of 14-3-3 protein, (D) Complex formation 
ofRaf-l, 14-3-3 protein, and ras p21. The lysates expressing Raf-1 and v-ras p21 (lane 1), Raf-1 and 14-3-3 protein (lane 2), or Raf-1, 14-3-3 protein, 
and v-ras p21 (lane 3) were immunoprecipitated with the anti-Raf-1 antibody. A big arrow, a small arrow, and an arrowhead indicate the positions 
of Raf-1, 14-3-3 protein, and ras p21, respectively. The results hown are representative of three independent experiments. 
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Fig. 3. Interaction of Raf(136-322) with 14-3-3 protein in COS cells. 
The lysates expressing 14-3-3 protein and Raf(1-322) (lane 1), 14-3-3 
protein and Raf(1 135) (lane 2), or 14-3-3 protein and Raf(136 322) 
(lane 3) were immunoprecipitated with the anti-Myc antibody. Arrows 
indicate the precipitated Raf-1 mutants. The results hown are repre- 
sentative of three independent experiments. 
but Raf(1-135) was not (Fig. 3). These results indicate that 
residues 1-135 and 136-322 constitute the binding domains for 
ras p21 and 14-3-3 protein, respectively. 
4. Discussion 
The experiments o determine the binding domain of Raf-1 
for ras p21 and 14-3-3 protein have been carried out using yeast 
two-hybrid and in vitro systems [4-9,11-17]. The experiments 
to show the physical interaction of these proteins in intact cells 
have been little done. Here we have characterized the binding 
domains of Raf-1 for ras p21 and 14-3-3 protein using intact 
cells. 
We have demonstrated that Raf(l-135) interacts with ras p21 
and that neither Raf(1-60) nor Raf(61-322) interacts with ras 
p21. These results uggest that residues 1-135 of Raf-1 contain 
ras p21-binding domain and that residues 1-60 lack a ras p21- 
binding domain but may be necessary for the interaction of 
residues 61 135 with ras p21. These results are consistent with 
the observations in vitro that residues 52-64 are essential for 
the interaction of Raf-1 with ras p21 although this region does 
not represent a direct binding domain for ras p21 [13]. It is 
conceivable that residues 1-60 are necessary to keep the ras 
p21-binding domain of Raf-1 in a binding conformation. Our 
results using intact cells taken together with the previous obser- 
vations [8,11-14] provide the basis of developing agents that 
may effectively inhibit the interaction of Raf-1 with ras p21 in 
vivo. 
We have shown for the first time that 14-3-3 protein mainly 
interacts with the N-terminal domain of Raf-1 in intact cells. 
Since the N-terminal domain of Raf-1 is believed to be its 
regulatory domain, 14-3-3 protein may regulate Raf-1 activity. 
In fact, microinjection of 14-3-3 protein in Xenopus  oocyte 
activates Raf-1 and overexpression f 14-3-3 protein in yeast 
stimulates the function of Raf-1 [15-17]. Therefore, 14-3-3 pro- 
tein may be at least a cofactor involved in the activation of 
Raf-1 by binding to the N-terminal domain of Raf-1. Further- 
more, we have demonstrated that Raf-1 simultaneously binds 
to both ras p21 and 14-3-3 protein and that the binding-domain 
of Raf-1 for ras p21 is distinct from the 14-3-3 protein-binding 
domain. It is known that ras p21 or 14-3-3 protein alone is not 
sufficient for Raf-1 activation [10,30]. Our results suggest hat 
ras p21 and 14-3-3 protein may cooperate to activate Raf-1 by 
their binding to the specific domains of Raf-1. Although it is 
not clear how ras p21 and 14-3-3 protein activate Raf-1, one 
possibility is that 14-3-3 protein could act to contribute the 
translocation of Raf-1 from the cytosol to the plasma mem- 
brane where the active form of ras p21 binds to Raf-1. Our 
observations favor this model. However, it has been recently 
reported that 14-3-3 protein weakly binds to and directly acti- 
vates the catalytic domain of Raf-1 whose the N-terminal do- 
main is deleted [29]. Indeed, our results have shown that the 
C-terminal domain of Raf-1 weakly binds to 14-3-3 protein. It 
is intriguing to speculate that 14-3-3 protein may activate Raf-1 
by two different ways. Further studies are necessary to under- 
stand the mode of activation of Raf-1 by ras p21 and 14-3-3 
protein. 
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